The arterial switch operation before Jatene.

Pediatric Cardiology
W N Evans

Abstract

Attempts at the arterial switch operation predated the Senning and the Mustard venous switch procedures. No patients survived the earlier arterial switch methods. Therefore, from the 1960s to the 1980s, venous switch surgeries became the dominant treatment method for transposition of the great arteries. The Brazilian cardiac surgeon, Adib Jatene, reported the first successful arterial switch in 1975. The history of the earlier arterial switches performed in the 1950s and 1960s is not well known. This article discusses that early history.

References

Jun 13, 1966·JAMA : the Journal of the American Medical Association·W J Rashkind, W W Miller
Jun 1, 1973·The Annals of Thoracic Surgery·C E Anagnostopoulos
Dec 1, 1984·British Heart Journal·E A Shinebourne
Aug 20, 1955·Lancet·M JONES, R N RAPOPORT
Jan 1, 1952·British Heart Journal·R ASTLEY, C PARSONS
May 21, 2004·Journal of Cardiac Surgery·Shafie FazelBernard S Goldman

❮ Previous
Next ❯

Citations

Jan 22, 2013·Cardiology in the Young·Ali Dodge-KhatamiJeffrey P Jacobs
Apr 13, 2011·Current Cardiology Reports·Susan Lucy RocheErwin Notker Oechslin
Feb 24, 2012·International Journal of Cardiology·Matina Prapa, Konstantinos Dimopoulos
Apr 23, 2015·Seminars in Cardiothoracic and Vascular Anesthesia·Gregory J LathamJeremy M Geiduschek
Apr 29, 2015·Seminars in Cardiothoracic and Vascular Anesthesia·Joshua L Hermsen, Jonathan M Chen
Jul 1, 2011·World Journal for Pediatric & Congenital Heart Surgery·Steven P Goldberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.